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Abstract 
Despite concerns about reporting biases and interpretation, self-assessed health (SAH) 
remains the measure of health most used by researchers, in part reflecting its ease of 
collection and in part the observed correlation between SAH and objective measures 
of health. Using a unique Australian data set, which consists of survey data linked to 
administrative individual medical records, we present empirical evidence 
demonstrating that SAH indeed predicts future health, as measured by 
hospitalizations, out-of-hospital medical services and prescription drugs. Our large 
sample size allows very disaggregate analysis and we find that SAH predicts more 
serious, chronic illnesses better than less serious illnesses. Finally we compare the 
predictive power of SAH relative to administrative data and an extensive set of self-
reported health measures, SAH does not add to the predictive power of future 
utilization when the administrative data is included and improves prediction only 
marginally when the extensive survey-based health measures are included. Clearly 
there is value in the more extensive survey and administrative health data as well as 
greater cost of collection. 
Running title: Does self-assessed health measure health? 
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1. Introduction 
Accounting for variations in health has become standard in many applied fields 
outside health economics. Prime examples include the importance of health in labour 
(Bound, 1991), consumption and savings (Jones and O’Donnell, 1995; De Nardi et 
al., 2010), portfolio choices (Rosen and Wu, 2004) and tourism (Hunter-Jones and 
Blackburn, 2007).  Recent results by Finkelstein, Luttmer and Notowidigdo (2013) 
suggest that variations in health impact on fundamentals in complex ways such as 
changing the curvature of the utility function, further supporting the inclusion of 
health measures in various fields of study.  
The notion of “true” health is itself a complex and multi-dimensional concept and 
various different measures of health have been used in practice depending on the 
availability of data and the research question. Still, the most pervasive measure 
remains self-assessed health (SAH). This variable is based on a survey question 
asking respondents to rate their general health usually on a five-point scale. It is easily 
asked and hence more readily available to researchers than most other measures. In 
addition, there exist robust findings of positive correlations between SAH and actual 
health and mortality; see for example Idler and Benyamini (1997), McCallum et al. 
(1994) and van Doorslaer and Gertham (2003).  
Despite its popularity, concerns remain about the validity of the SAH variable (we 
provide more details with references below) and there is a lot of uncertainty regarding 
what exactly SAH is measuring. In this paper we ask two main questions: Does SAH 
measure health? How well does SAH perform compared to other more objective 
measures of health in predicting future health? We are able to address these questions 
with the use of a rich data set that combines administrative panel data on detailed and 
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comprehensive health care utilization with survey data also containing an extensive 
range of health questions along with the standard socio-economic and demographic 
characteristics. To our knowledge, we are the first paper to assess the usefulness of 
SAH using a large sample survey linked to comprehensive health claims data. 
The empirical strategy involves the use of prospective models to investigate the 
association between SAH and a range of future health outcomes as measured by 
future health care utilization. We look separately at the relationship of SAH with 
various types of health care (hospital admissions, out-of-hospital medical services and 
prescription drugs) as well as major illnesses. We also compare the performance of 
SAH as a predictor of future health to that of other more objective survey health 
measures and to the administrative health data. Finally we briefly investigate the 
interaction of SAH with other non-health controls in predicting future health in the 
absence of extensive health controls. This may be useful to researchers faced with the 
usual dataset including a SAH variable but no other health measures and who have to 
make decisions on which controls to include in their specifications. 
We find that low self-assessed health substantially increases the utilization of health 
care services. For example, in specifications with a wide range of socio-economic and 
demographic controls as well as family health history variables, the effects of poor 
SAH (relative to excellent) vary from 39 percent to 54 percent relative to the mean 
utilization rates across different health care services. Interestingly, the effects of SAH 
are stronger for the more serious illnesses such as cancer. We take these results as 
convincing evidence that SAH does have actual health content.  
However, our results also suggest that the predictive power of SAH is surpassed by 
both the administrative data and by self-reported variables on health problems. 
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Specifically, objective health measures obtained from past administrative data (e.g., 
diagnoses from past hospitalization) are the most predictive of an individual’s future 
health care utilization followed by self-reported health measures. Hence there is a 
value in investing in data collection, especially administrative records and including 
extensive health questions in a survey.  
2. Literature on SAH 
A major concern with the use of SAH as measuring “health” stems from results on 
reporting biases related to various individual characteristics. For example, researchers 
have found discrepancies between SAH and more objective health measures related to 
sex (Arber and Cooper, 2006), income (Humphries and van Doorslaer, 2000; 
Hernandez-Quevedo et al., 2004; Etilé and Milcent, 2006) and nationality (Jürges, 
2007). An alternative approach based on vignette anchoring has suggested variation in 
reporting behaviour based on age (Lindeboom and van Doorslaer, 2004), education 
(Bago d'Uva et al., 2008) and country of residence (Salomon et al., 2004).  
Crossley and Kennedy (2002) use a natural experiment where some respondents 
answer the SAH question twice to show that SAH responses vary depending on 
whether the question is asked before or after a series of objective health questions 
suggesting a learning effect. Other sources of errors are related to a lack of awareness 
of health problems (Johnston et al., 2009) and the presence of incentives for 
misreporting (Bound, 1991; Gupta and Jürges, 2012 and references within). Given the 
number and variety of reporting biases found in the literature, it is  natural and 
appropriate to ask what SAH actually measures (Layes et al., 2012 and references 
therein).  
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Several studies have focused on the predictive power of SAH on survival. Early 
papers found that SAH did in fact predict mortality (McCallum et al., 1994 and 
studies reviewed in Idler and Benyamini, 1997) but tended to concentrate on smaller 
samples of older adults. More recent papers also found that SAH has predictive power 
for mortality and moreover that the predictive power varies negatively with age (van 
Doorslaer and Gerdtham, 2003) and positively with education at least for men 
(Huisman et al., 2007). Jylhä (2009) discusses pathways in which SAH may predict 
mortality.  
Recent studies find that SAH has predictive power with respect to other health 
outcomes as well. Lee (2000) finds that SAH predicts not only mortality, but also 
functional decline while Møller et al. (1996) find that, even after controlling for risk 
factors and other potential confounders, those reporting poor and miserable SAH have 
6.5 and 18.6 fold higher risk of fatal and non-fatal coronary heart disease, 
respectively, than those reporting extremely good SAH. Wu et al. (2013) find that 
unhealthy individuals have at least twice the odds of contracting an array of chronic 
diseases than their healthy counterparts, and are also more likely to have poor spiritual 
status and poor quality of interpersonal relationships. Manor et al. (2001) find that 
SAH predicts more serious conditions like heart diseases, cancer and diabetes better 
than less serious conditions like high blood pressure, migraine, eczema and hay fever. 
Finally, Vie et al. (2014) find that SAH during adolescence (aged 12-20) is a 
significant predictor of allostatic load in adulthood.  
Relatively few studies examine the impact of SAH on health care utilization 
(Connelly et al. 1989; Miilunpalo et al., 1997; Long and Marshall 1999). Using the 
same survey data as the one used in this study linked to administrative emergency 
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department records, Johar et al. (2013) find a strong negative SAH gradient in 
presentations to an emergency department. Ellis et al. (2013) show that SAH has 
strong predictive power over aggregate health care expenditure, but did not explore 
which component specifically of the health care that SAH predicts.   
The contribution of this study revolves around the superior dataset we use. As 
discussed above, existing studies have focused on restrictive samples and/or 
restrictive health outcomes. With a large representative sample of adults over 45 years 
of age we are able to look at the predictive power of SAH on a comprehensive set of 
future health outcomes in a consistent fashion.  In particular, the large size of our 
sample makes it possible to identify and credibly examine relationships between SAH 
and relatively rare illnesses, such as cancer. Secondly, most of the above mentioned 
studies use self-reported illnesses and physical health scores, such as SF-36, as 
measures of objective health, and these may be reported with errors. This study is 
based on both extensive administrative and self-reported survey data. Hence we have 
access to more accurate data and we can compare the performance of health measures 
based on self-reports and those based on actual utilization of health services. 
Additionally, under Australian universal free health care system, the bias arising from 
failing to capture sick people who do not seek medical treatment is likely to be 
minimal. Finally, the richness of the survey data allows us to include extensive 
controls such as family history of chronic illnesses that have been omitted in the past.  
 
3. Method  
The aim of this study is first to test the health content of SAH. Our identification 
strategy relies on the timing of events (prospective models) and the inclusion of an 
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extensive set of controls along with SAH to understand the impact of confounding 
factors. Specifically, we estimate multivariate models of various health care 
utilization measures at time t+1 as functions of SAH and extensive control variables 
at time t. These models will confirm whether or not SAH has independent effects on 
prospective health outcomes. Also, the use of extensive controls improves the 
comparability of SAH across individuals by reducing reporting errors and biases due 
to differences in health-threshold levels and reporting norms across subgroups. We 
exclude a set of these control variables one at a time to assess the sensitivity of SAH 
coefficients to omitted variables.  
As an additional analysis, we restrict attention to a homogenous sub-sample of 
relatively healthy individuals and we compare the effect of SAH on future health care 
utilization for the sub-group of these healthy individuals who experience a negative 
health shock in the form of a hospital admission at time t-1 with the remaining healthy 
respondents. For this experiment, an individual is defined as relatively healthy if 
he/she was not admitted to hospital and not diagnosed with a chronic condition up 
until two years ago. If SAH is measuring actual health, then in any category of SAH 
there is likely to be a group with stable health and a group who are experiencing 
worsening health and hence are more likely to have transitioned into their current 
SAH level from a better level. Thus, we expect the effect of SAH on prospective 
health outcomes to be stronger for individuals who experience a health shock, as it is 
picking up both the level of health and its change.  
We also compare the predictive power of SAH across illness groups. The illness 
groups are defined by collating medical codes and service numbers of inpatient and 
outpatient utilizations. Separate models are estimated for each illness group. 
8 
 
Additionally, we explore heterogeneity in the health content of SAH along the 
dimensions of age, sex and education by including their interaction terms with SAH.  
Finally, we assess the relative usefulness of SAH compared to other health measures 
by replacing SAH with self-reported health problems from the survey and past 
utilization from the administrative data. We record the explanatory power of these 
models (using pseudo R-squared) and compare them.   
 
4. Data 
The data are derived from four data sets. The first source is the 45 and Up Study, 
which is a cross-section survey of non-institutionalized individuals aged 45 and over 
(45+) in the state of New South Wales (NSW), Australia. NSW is the most populous 
state in Australia with a population of about 7.3 million, 39 percent aged over 45. The 
45 and Up Study consists of over 267,000 respondents, surveyed once during 2006–
2010, with the largest collection taking place in 2008 (about 80 percent). The 
variation in survey years is part of the data collection design and is not a choice for 
respondents. A random selection of persons within the 45+ population is chosen from 
the Medicare Australia database for the survey. People over 80 years of age or 
resident in rural and remote areas were oversampled. The Medicare database covers 
everyone who has access to public health insurance (basically all permanent residents 
in Australia). The survey collects extensive information about the respondents’ 
current health status, quality of life and history of own, parents’ and siblings’ chronic 
illnesses, as well as demographic and socio-economic characteristics.  
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The 45 and Up Study can be linked to multiple health administrative data sets at the 
respondent level. Only a few survey-administrative data linkages of this scale exist 
anywhere in the world and it is unique in Australia. The three administrative 
databases used in this study are: the NSW Admitted Patient Data Collection (APDC), 
the Medicare Benefits Schedule (MBS) and the Pharmaceutical Benefits System 
(PBS). The APDC data includes all hospital separations by the survey respondents 
during 2000-2009; the MBS data consist of out-of-hospital medical services for which 
a Medicare subsidy was paid and the PBS data includes prescription drugs for which a 
Medicare subsidy was paid during 2006-2009. About 80 percent of prescription drugs 
dispensed in Australia are subsidized.  
To apply a one-year prospective framework and to have available past health care 
utilization, we focus on the survey respondents who completed the survey in 2007 and 
2008 (226,121 observations). A few respondents with invalid age and sex or who 
were unsolicited for the survey were excluded. To deal with missing data, we 
computed the percentage of observations with missing values for each variable in the 
models. If more than 1 percent of observations had missing values, the observations 
were kept and dummy variables for missing information were added to the model. If 
less than 1 percent of observations had missing values, the observations with missing 
values were deleted. Our final analysis sample consists of 212,574 observations (80 
percent of the original sample). We note that in order to conduct the analysis at the 
level of disaggregation we use, large samples are crucial. 
In the health care utilization models, separate logit regressions are estimated for 5 
dependent variables. These are binary variables defined over the 12 months following 
the survey date; the calendar time covered by these variables is specific to the 
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individual in that it depends on the date at which the respondent completed the 
survey. The utilization variables are:  
1. Hospital, a binary variable equal to 1 if the respondent had at least one hospital 
admission (private or public); 
2. GP, a binary variable equal to 1 if the respondent had more than 6 normal-length 
general practitioner (GP) consultations; 
3. Specialist, a binary variable equal to 1 if the respondent had at least one specialist 
visit;  
4. Other medical, a binary variable equal to 1 if the respondent had more than 10 of 
any of the following non-specialist out-of-hospital medical services: haematology, 
psychology, ophthalmology, pathology, physiotherapy, podiatry and radiation 
oncology;  
5. Drugs, a binary variable equal to 1 if the respondent consumed more than 2 types 
of drug groups (explained below).  
For all 5 variables, the threshold used to switch the dummy variable to 1 corresponds 
to the sample median. We prefer this binary transformation because it facilitates 
comparison across types of utilization and because counts are sensitive to rare, 
extreme observations, which may lead to misleading results. Nevertheless, as a 
robustness check, we also estimate negative binomial models for count data. To avoid 
bias due to extreme users, for each outcome, we exclude observations in the top 1 
percent of the distribution. 
To define drug groups or types of drugs, we use the first digit of the Anatomical 
Therapeutic Codes (ATC). We focus on drug groups rather than individual drugs for 
several reasons. A consumption of multiple drug groups indicates comorbidities. 
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Also, the use of drug groups minimises potential bias due to the data limitation which 
only covers subsidized drugs; essentially we are exploiting substitutability or 
complementary between drugs for a given condition, where at least one of them is 
subsidized.  
We gather the information from hospital diagnoses (International Classification of 
Disease version 10 codes of primary diagnosis), specialities of specialist visits (MBS 
item numbers) and ATC drug groups to define 14 major illness groups for the illness 
models. Table 1 details this mapping, illustrating the scope of our analysis. As for the 
utilization outcomes, prospective models are used; specifically, illnesses are defined 
by binary variables measuring the incidence of treatment for the illness in the 12 
months following the survey date. Note that as for utilization variables, the 14 
outcomes representing illnesses are not mutually exclusive as an individual with 
comorbidities (across the illness groups) will have a dependent variable equal to 1 for 
more than one illness outcome. Separate logit regressions are estimated for the 14 
illness groups. 
[Insert Table 1] 
The SAH information is obtained from the survey data. This variable is based on a 
five-point scale answer to the question “In general, how would you rate your health?” 
The scale reflects the 5 possible choices: excellent, very good, good, fair and poor. 
Since there are only a small number of respondents who rate their health as poor (less 
than 5 percent), we combine fair and poor responses together representing the 
unhealthiest group of sample respondents. At the other end of the spectrum, the 
healthiest group consists of those reporting excellent or very good SAH. The sample 
proportions in the three SAH groups are: 50.7 percent excellent or very good, 32.6 
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percent good and 13.5 percent fair or poor (3.2 percent of the sample did not report 
their SAH).  
We compare the predictive power of SAH to two types of more objective 
health measures. The first group comes from the 45 and Up survey and consists of 
self-reported diagnoses of illnesses (skin cancer, melanoma, other cancer, heart 
disease, stroke, diabetes, blood clot, asthma, hay fever, Parkinson’s disease, 
depression and anxiety) and daily health limitations (physical functioning and mental 
distress, as measured by the Kessler psychological distress scale), 15 variables in 
total. The second group of objective health measures includes past utilization 
variables that are constructed using the historical dimension of the linked 
administrative data. In effect, we are including a vector of lagged dependent variables, 
although all past utilization measures are disaggregated by illness and the time frame 
covered by these lagged variables is in some cases longer than the one-year-ahead 
time frame used for the dependent variables. Specifically, we add illness-specific 
hospital admissions in the past five years and out-patient service and prescription drug 
use in the last 12 months from the survey date (136 variables).  
We also control for an extensive list of individual characteristics. The survey data 
contain information about the respondents’ demographic (age, sex, residential 
location, marital status, country of birth, language etc.) and socio-economic 
characteristics (education, income, employment, health insurance, housing) lifestyle 
(smoking, alcohol consumption, body weight), as well as family health history 
(parents’ and siblings’ illnesses). We also control for self-reported quality of life 
(QoL). Like SAH, QoL is likely to be influenced by reporting norms and biases and 
its inclusion in the model will help control for the reporting style of respondents. 
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Although some of the control variables may be correlated with unobserved aspects of 
health, we refer to them as “non-health” variables. In total, there are 65 such controls 
(98 variables). 
 
5. Results  
5.1. Descriptive statistics 
Table 2 presents the means of the main control variables by self-assessed health 
status. People in worse SAH are older and/or more likely to engage in unhealthy 
lifestyle (except for alcohol consumption). There is also variation in SAH by socio-
economic status, as measured by education, household income, and an index of 
relative socioeconomic advantage measured at the local area level (SEIFA), with 
more socio-economically advantaged individuals tending to report better health. As 
expected there is a strong and positive correlation between SAH and quality of life. 
[Insert Table 2] 
Means of the outcome variables by SAH status are presented in Table 3. Worse SAH 
is positively associated with the utilization of all types of health care services, 
especially drugs, in the 12 months following the survey date. The incidence of all 
illnesses in the next 12 months is also higher among the respondents in worse health.  
[Insert Table 3] 
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5.2.Health content of SAH 
Our first research question asks how much health content there is in the self-assessed 
health variable. Panel A of Table 4 presents the logit average partial effects of good 
and poor SAH (relative to excellent or very good health) on the utilization of various 
health services in the next 12 months. The regressions in panel A control for all non-
health variables described in Section 4. The results show that there is a significant 
positive relationship between worse SAH and future health care utilization even after 
controlling for extensive demographic, socio-economic, lifestyle, family health 
history and quality of life variables. Worse SAH is found to increase utilization of all 
major health care services in the next 12 months, although there is some variation in 
the effects across services. The finding that SAH predicts a variety of health care 
services and not only visits to GPs who are gatekeepers in the Australian health care 
system, does not support the common scepticism that SAH merely captures “worried 
well” individuals who need reassurances from their doctor.  
Relative to those with very good health, those in slightly worse health have 5 
percentage points higher probability of hospitalization and 9-10 percentage points 
higher probability of out-of-hospital services utilization, while those in fair/poor 
health have 14 percentage points higher probability of hospitalization and 18-21 
percentage points higher probability of out-of-hospital services utilization. The 
gradient in the SAH effects is clear and is a pervasive feature of the results to follow. 
Relative to the mean utilization rates, the effects of poor SAH are largest on 
hospitalizations (54 percent relative to the mean of 0.256) and prescription drug use 
(52 percent relative to the mean of 0.406).  
[Insert Table 4] 
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We also check how important it is to control for the non-health variables, especially 
the variables that may not be available in other surveys. Panels B, C, D, E and F of 
Table 4 show how the average partial effects of good and poor SAH change when we 
omit demographic, socio-economic status (SES), lifestyle, family health history and 
quality of life (QoL) variables, respectively. The coefficients on SAH are somewhat 
affected by the omission of SES, lifestyle and QoL variables. For example, the effect 
of poor SAH on GP visits increases from 18.1 to close to 20 percentage points when 
SES, lifestyle or QoL variables are not included in the regression. The effects of SAH 
on the use of other medical services and prescription drugs also increase slightly, but 
SAH effects on specialist visits and hospitalizations are quite insensitive to the 
omission of these controls. Omitting demographic variables or information about 
family health history affects the coefficients on the SAH variables even less than 
omitting SES, lifestyle or QoL variables. These findings suggest that it may not be 
necessary to have such a rich set of controls as we do in our models. A more 
parsimonious model, which controls for the usual individual characteristics and QoL 
(or other variables capturing an individual’s reporting style) may suffice.  
As a sensitivity check on the decision to discretise the health outcomes into binary 
variables, we estimate negative binomial models for the number of GP and specialist 
visits, other medical services and prescription drug types. We do not perform this 
exercise for hospitalization because most hospitalization cases happen only once in a 
year. To avoid excessive influence by outliers, we omit the one percent highest users 
of each health care service (in the estimation of the regression on that service only). 
Two models are estimated. The first is a standard count data model, while the second 
is a latent class model with two classes. The latter model allows for unobserved 
heterogeneity in the effects of SAH and other variables. (For drugs, the latent class 
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model has convergence problems, so we only present negative binomial model 
results.) 
The results of the count data models, presented in Table 5, are consistent with the 
results of the logit models. For all dependent variables and both types of count data 
models, we find that worse SAH increases utilization of health care services in the 
next period, and that these effects are statistically and economically significant.  
 [Insert Table 5] 
Table 6 presents results for the subset of respondents classified as “healthy”. Close to 
18 percent of the sample are defined as being relatively healthy according to our 
definition (described in Section 3). As expected, the proportion of individuals in 
excellent or very good health is higher in this subsample (65.36 percent) than in the 
rest of the sample (48.37 percent). Around 12 percent of the “healthy” individuals had 
a health shock (a hospitalization) in the past year. The proportion of individuals in 
excellent or very good SAH is lower among the hospitalized respondents (60.43 
percent) than among those who did not have a hospitalization (66.03 percent), 
indicating that individuals do adjust their SAH in response to health shocks. Rows 1 
and 3 report average partial effects of SAH for the respondents who remained healthy, 
that is, were not hospitalized in the past 12 months and rows 2 and 4 report the 
average partial effects of SAH for the respondents who had a recent health shock.2 
The effects of worse SAH on all outcomes are larger for the respondents who 
experienced a health shock. The effect of poor SAH on GP visits is twice as large in 
the subsample of people who had a hospitalization last year as in the subsample of 
                                                 
2 In rows 1 and 3, the reference group is people with excellent health who have not experienced a 
health shock. In rows 2 and 4, the reference group is people with excellent health who have 
experienced a health shock. The effect of excellent health is normalized to zero for both groups. 
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people who were not hospitalized. The differences in the effects of poor SAH between 
these two groups are even larger in the case of specialist visits, other medical service 
use and hospitalizations. The interpretation of these results is that for these 
respondents the variation in SAH is more likely to represent a variation in actual 
health. These findings again support the hypothesis that SAH measures health rather 
than personality or reporting style. 
[Insert Table 6] 
5.3.Heterogeneity in the impact of SAH 
Results presented in Table 7 show that SAH is more closely related to certain illnesses 
than others. As a proportion of the mean, poor SAH has especially large effects on the 
probabilities of cancer and diseases of the respiratory and endocrine systems. SAH is 
least related to skin and eye diseases, which are arguably less serious. This evidence 
suggests that SAH responds more to symptoms associated with more serious illnesses 
and is consistent with the results of Manor et al. (2001) on British data. Although not 
reported, we find that, except for musculoskeletal disorders, SAH affects both in-
hospital and all of the out-of-hospital services. For musculoskeletal disorders, poor 
SAH has large positive and statistically significant effects on drugs and certain out-of-
hospital medical services (by rheumatologists, physiotherapists and podiatrists) but 
has no effect on in-hospital services.   
[Insert Table 7] 
Table 8 presents the average partial effects of SAH by gender and education 
(university education or not) and Figure 1 plots the average partial effects across the 
age distribution. Past literature has generally identified reporting heterogeneity in 
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SAH along these dimensions so here we test whether such heterogeneity also carries 
through to the impact of SAH on future health. There is significant heterogeneity by 
age and gender, but interestingly the differences in SAH effects by education are not 
statistically significant. SAH is more strongly related to future health care utilization 
for females than males which may be explained by the common trend that females are 
more likely to seek medical treatment than males. Meanwhile, we think that the lack 
of heterogeneous impact by education may be due to the counteracting effects of 
reporting bias and preference for health care. Past studies have found that highly 
educated individuals are more pessimistic when asked about their subjective health 
(Bago d’Uva et al., 2008), but at the same time they are also more likely to seek 
treatment when sick.  
The impact of SAH on future utilization varies non-linearly with age, especially for 
out-of-hospital services. The effects of SAH peak at around 55-60 years of age and 
decrease after. The decline is steeper in the case of poor SAH than in the case of good 
SAH. The observed decline in the effects of SAH with age may be explained by the 
fact that the expected health gains from an additional treatment for older individuals 
are smaller compared to an additional treatment for younger individuals, or 
alternatively that extra treatments may increase health risks. This result could also 
mean that SAH has less health content among older individuals. 
[Insert Table 8] 
[Insert Figure 1] 
5.4.Comparison of the predictive power of SAH and more objective health measures 
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Our second research question looks at the predictive power of SAH relative to other 
health measures. To address this issue, we estimate models with various combinations 
of the three groups of health variables (SAH, the self-reported diagnoses of illnesses 
obtained from the survey data and the past health care utilization variables obtained 
from the administrative records) and compare the pseudo R-squared statistics from 
these regressions. Table 9 presents the pseudo-R-squared statistics for the five future 
health care utilization measures we are predicting. The first row presents the statistics 
for models without any health controls. The rows below it present corresponding 
figures for models in which the three groups of health variables are included in 
various combinations.  
[Insert Table 9] 
The use of our extensive set of survey-based objective health variables instead of the 
one SAH variable (comparing rows 2 and 3) raises the pseudo R-squared statistic by 7 
to 25 percent across the five models. When comparing SAH to the information from 
the administrative data (comparing rows 2 and 4), the pseudo R-squared rises by a 
factor of up to 3. When adding SAH to regressions containing the other survey-based 
health measures (comparing rows 3 and 5), the pseudo R-squared increases by 1 to 3 
percent only while the impact of adding SAH to the administrative data (comparing 
rows 4 and 6) is negligible.  
Our results show that, given the choice, one would prefer the use of the administrative 
data. This is perhaps not surprising since in this case, the administrative variables are 
in essence lagged values of the dependent variables. The more interesting result is that 
although adding health information (the coefficients on SAH remain significant in all 
models), SAH does not improve the predictive power in the case of the administrative 
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data and does so only marginally in the case of the survey-based objective health 
measures. Having said this, we are comparing the power of one easily collected 
variable with a set of 15 possibly sensitive, survey-based health variables and with 
rare administrative utilization data (136 variables).  The overall conclusion is that 
there is value in collecting the more extensive data and using them in predicting future 
health care utilization. However, in the absence of administrative information, both 
SAH and self-reports of illnesses should be used to predict future health. 
 
6. Conclusion 
Health is complex and the notion of a perfect health index is difficult to define let 
alone measure. In this paper, we use a unique dataset constructed from merged survey 
and health administrative data sets to investigate whether the commonly used self-
assessed health measure is in fact capturing “health” in a meaningful sense. Our 
empirical strategy consists of evaluating the usefulness of SAH compared to more 
objective health measures and its predictive power on various types of future health 
care utilization variables. We then use the utilization information to define 
comprehensive illness groups to investigate if SAH is more closely related to some 
illnesses better than others. Additionally, we explore if there is variation in SAH 
effects by common sources of reporting heterogeneity in SAH responses (gender, age 
and education). 
All of our results suggest that the common self-reported health index does capture 
health in that it is strongly related to future health service utilization, especially 
specialist visits and hospital admissions, over and above personal characteristics. 
Importantly, we find significant impact of SAH across all illness groups, but 
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individuals appear to place more weight on symptoms leading to more serious 
illnesses, which SAH predicts better than less serious illnesses. The impact of SAH is 
found to be larger for females and younger (45+) individuals. Overall, our results 
confirm the interpretation of SAH as a useful indicator of objective health, however, 
compared to objective health measures, SAH has less predictive power. Given the 
choice, inclusion of administrative data would perform better followed by survey-
based illnesses measures.    
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Table 1. Definitions of illness groups. 
No Hospital Diagnoses  Outpatient Specialities Drug Groups 
1 Infectious disease   Anti-infectives for systemic use 
2 Neoplasm (cancer) Medical Oncology  Antineoplastic and immuno-modulating 
agents 
3 Blood disease Haematology Blood and blood forming organs 
4 Endocrine, nutritional 
or metabolic  disease 
Endocrinology 
Immunology 
Drugs for diabetes 
Systemic hormonal preparations 
5 Mental disorder Psychiatry Mental disorders  
  Psychology  
6 Disease of nervous 
system 
Neurology  Nervous system 
7 Disease of eye Ophthalmology 
 
Ophthalmologicals 
8 Disease of ear, nose 
or throat 
Otorhinolaryngology Otologicals 
9 Disease of circulatory 
system  
Cardiology Cardiovascular system 
Lipid modifying agents 
    
10 Disease of respiratory 
system 
Thoracic medicine Respiratory system 
11 Disease of digestive 
system 
Gastroenterology 
General surgery 
Alimentary tract and metabolism 
12 Disease of skin Dermatology Dermatological 
  Plastic  
13 Disease of 
musculoskeletal 
system 
Rheumatology 
Orthopaedics 
Physiotherapy 
Musculoskeletal system 
  Podiatry  
14 Genitourinary disease Renal Genitourinary system and sex hormones 
  Urology  
   Obstetrics and 
Gynaecology 
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Table 2. Means of main control variables by self-assessed health status 
  
Excellent/ 
very good Good Fair/poor 
Male 0.436 0.488 0.494 
Age in years 60.86 (10.10) 63.65 (11.36) 65.89 (12.24) 
Born in Australia a 0.765 0.754 0.747 
Born in English speaking country 0.139 0.117 0.097 
Speaks other language at home 0.072 0.104 0.134 
Australian ancestry 0.521 0.524 0.529 
English/Irish/Scottish ancestry 0.608 0.582 0.553 
Other European ancestry 0.111 0.118 0.121 
Other ancestry 0.127 0.147 0.168 
Married/lives with partner 0.799 0.743 0.656 
Number of children 2.41 (1.39) 2.47 (1.48) 2.53 (1.65) 
Doesn't have any qualifications a 0.076 0.128 0.218 
Has school/intermediate certificate 0.203 0.242 0.245 
Has higher school certificate 0.099 0.101 0.097 
Has trade/apprenticeship 0.098 0.127 0.129 
Has certificate/diploma 0.229 0.210 0.171 
HH income less than $5000 pa a 0.010 0.016 0.032 
HH income $5000-$9999 pa 0.022 0.041 0.082 
HH income $10000-$19999 pa 0.094 0.165 0.254 
HH income $20000-$29999 pa 0.084 0.109 0.113 
HH income $30000-$39999 pa 0.083 0.086 0.067 
HH income $40000-$49999 pa 0.080 0.076 0.054 
HH income $50000-$69999 pa 0.123 0.104 0.065 
HH income missing 0.182 0.202 0.222 
SEIFA Index of Relative Socioeconomic 
Advantage & Disadvantage 1014.15(87.85) 1001.34(82.94) 991.35(78.80) 
Employed 0.569 0.437 0.255 
Lives in a flat a 0.095 0.111 0.139 
Lives in a house on farm 0.087 0.070 0.055 
Lives in other housing 0.029 0.050 0.080 
Accessibility/Remoteness Index of Australia b 1.22 (1.67) 1.25 (1.71) 1.26 (1.78) 
Private health insurance 0.731 0.628 0.470 
    
    
    
    
    
    
    
    
    
    
    
28 
 
    
Takes vitamins/supplements 0.516 0.512 0.470 
Number of alcoholic drinks per week 7.24 (8.84) 7.05 (10.12) 6.09 (10.97) 
Smokes now a 0.047 0.082 0.122 
Smoked before, not now 0.336 0.371 0.396 
Body mass index 26.16 (4.56) 27.88 (5.44) 28.93 (6.71) 
Quality of life good a 0.065 0.564 0.359 
Quality of life fair or poor 0.010 0.067 0.517 
Quality of life missing 0.021 0.027 0.037 
Sample proportion 0.507 0.326 0.135 
Notes: Sample size is 212,574.For continuous variables, standard deviations are in parentheses. a 
Omitted categories are born in non-English speaking country, university degree, HH income $70,000 
pa or more, lives in a house, and never smoked,  excellent/very good quality of life, respectively. b 
Varies from 0 (very accessible) to 15 (very remote).  
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Table 3. Means (sample proportions) of outcome variables by self-assessed health status 
  Excellent/very good Good Fair/poor 
HC service utilization:    
GP 0.341 0.520 0.684 
Specialist 0.419 0.525 0.647 
Other medical 0.388 0.530 0.668 
Drugs 0.264 0.486 0.710 
Hospital 0.202 0.277 0.394 
Illnesses:    
Infection 0.215 0.346 0.531 
Cancer 0.057 0.087 0.138 
Blood 0.140 0.248 0.402 
Endocrine 0.097 0.207 0.387 
Mental 0.107 0.199 0.386 
Nervous 0.132 0.268 0.490 
Eye 0.513 0.560 0.594 
Ear, nose, throat 0.057 0.079 0.116 
Circulatory 0.378 0.577 0.724 
Respiratory 0.098 0.173 0.308 
Digestive 0.281 0.422 0.582 
Skin 0.175 0.209 0.268 
Musculoskeletal 0.213 0.346 0.492 
Genitourinary 0.129 0.173 0.238 
Sample proportion 0.507 0.326 0.135 
Note: Sample size is 212,574. Details on the definition and the construction of the outcome variables 
are provided in the main text and Table 1. 
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Table 4. Average partial effects of SAH on future health care utilization across different 
specifications 
  GP Specialist 
Other medical 
services Drugs Hospital  
A. All non-health controls  
Good SAH 0.094*** 0.087*** 0.091*** 0.102*** 0.053*** 
 
(0.003) (0.003) (0.003) (0.002) (0.003) 
Fair/poor SAH 0.181*** 0.192*** 0.188*** 0.209*** 0.137*** 
 
(0.004) (0.004) (0.004) (0.004) (0.004) 
B. Demographics left out  
    Good SAH 0.102*** 0.090*** 0.095*** 0.110*** 0.059*** 
 
(0.003) (0.003) (0.003) (0.002) (0.003) 
Fair/poor SAH 0.187*** 0.192*** 0.190*** 0.214*** 0.145*** 
 
(0.004) (0.004) (0.004) (0.004) (0.004) 
C. SES left out  
     Good SAH 0.102*** 0.087*** 0.095*** 0.112*** 0.053*** 
 
(0.003) (0.003) (0.003) (0.002) (0.003) 
Fair/poor SAH 0.199*** 0.192*** 0.197*** 0.244*** 0.136*** 
 
(0.004) (0.004) (0.004) (0.004) (0.004) 
D. Lifestyle left out  
    Good SAH 0.103*** 0.089*** 0.096*** 0.115*** 0.056*** 
 
(0.003) (0.003) (0.003) (0.002) (0.003) 
Fair/poor SAH 0.197*** 0.195*** 0.195*** 0.233*** 0.144*** 
 
(0.004) (0.004) (0.004) (0.004) (0.004) 
E. Family health history left out  
    Good SAH 0.098*** 0.090*** 0.094*** 0.107*** 0.054*** 
 
(0.003) (0.003) (0.003) (0.002) (0.003) 
Fair/poor SAH 0.189*** 0.197*** 0.194*** 0.219*** 0.140*** 
 
(0.004) (0.004) (0.004) (0.004) (0.004) 
F. QoL left out  
     Good SAH 0.101*** 0.089*** 0.094*** 0.106*** 0.055*** 
 
(0.002) (0.002) (0.002) (0.002) (0.002) 
Fair/poor SAH 0.199*** 0.201*** 0.194*** 0.224*** 0.155*** 
 
(0.003) (0.003) (0.003) (0.003) (0.003) 
Mean of dep.var. 0.453 0.487 0.478 0.406 0.256 
Notes: Sample size is 212,574. Average partial effects are based on logit models. Robust standard 
errors are in parentheses. Non-health controls include demographic, SES, lifestyle, family health 
history and QoL variables and year effects. The omitted group for SAH is excellent or very good. 
Symbols *, **, and *** indicate significance at the 10%, 5%, and 1% level, respectively.  
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Table 5. Count data model results. 
  GP Specialist 
Other medical 
services Drugs 
A. Negative binomial model  
   Good SAH 0.139*** 0.253*** 0.164*** 0.251*** 
 
(0.005) (0.011) (0.006) (0.005) 
Fair/poor SAH 0.219*** 0.449*** 0.292*** 0.360*** 
 
(0.007) (0.016) (0.009) (0.008) 
B. Latent class negative binomial model 
Latent class 1 
    Good SAH 0.083 0.218*** 0.266*** - 
 
(0.053) (0.013) (0.017) - 
Fair/poor SAH 0.266** 0.415*** 0.426*** - 
 
(0.082) (0.018) (0.026) - 
Class 1 probability 0.065 0.334 0.339 - 
Latent class 2 
    Good SAH 0.192*** 0.717*** 0.202*** - 
 
(0.005) (0.028) (0.009) - 
Fair/poor SAH 0.366*** 1.405*** 0.479*** - 
 
(0.007) (0.038) (0.013) - 
Class 2 probability 0.935 0.666 0.661 
 Sample size  210613 210651 210530 211686 
Mean of dep.var. 7.57 2.11 14.45 2.66 
 
Notes: Sample size is 212,574. Robust standard errors are in parentheses. All count regressions control 
for demographic, SES, lifestyle, family health history and QoL variables and year effects. The omitted 
group for SAH is excellent or very good. Symbols *, **, and *** indicate significance at the 10%, 5%, 
and 1% level, respectively.  
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Table 6. Variation in average partial effects of SAH in “healthy” subsample 
  GP Specialist 
Other 
medical 
services Drugs Hospital  
Good health           
Health shock: No  0.034*** 0.026*** 0.038*** 0.015*** 0.012* 
 
(0.006) (0.007) (0.007) (0.004) (0.005) 
Health shock: Yes 0.035** 0.039** 0.045** 0.040*** 0.015 
 
(0.013) (0.015) (0.014) (0.008) (0.013) 
Fair/poor health 
     Health shock: No  0.038** 0.063*** 0.057*** 0.032*** 0.029** 
 
(0.012) (0.014) (0.013) (0.007) (0.011) 
Health shock: Yes 0.080*** 0.171*** 0.174*** 0.042** 0.089*** 
  (0.024) (0.030) (0.029) (0.013) (0.025) 
Note: Sample size is 37,243. Robust standard errors are in parentheses. Health shock is defined as a 
hospitalization in the past 12 months. All logit regressions control for demographic, SES, lifestyle, 
family health history and QoL variables, year effects, and health care utilization in the past year.  The 
omitted group for SAH is excellent or very good. Symbols *, **, and *** indicate significance at the 
10%, 5%, and 1% level, respectively. 
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Table 7. Variation in average partial effects of SAH by illnesses 
  
Good 
SAH     Fair/poor SAH   
  Coeff. S.E. 
% change 
from mean Coeff. S.E. 
% change 
from mean 
Respiratory 0.109*** (0.003) 70.88 0.194*** (0.004) 125.95 
Cancer 0.033*** (0.002) 42.05 0.086*** (0.004) 108.98 
Endocrine 0.077*** (0.002) 43.46 0.189*** (0.004) 106.72 
Blood 0.064*** (0.002) 29.94 0.161*** (0.004) 74.65 
Nervous 0.066*** (0.002) 28.41 0.160*** (0.004) 69.39 
Mental 0.041*** (0.002) 23.09 0.112*** (0.004) 62.58 
Digestive 0.093*** (0.003) 24.97 0.199*** (0.004) 53.32 
Genitourinary 0.032*** (0.002) 20.11 0.076*** (0.004) 47.45 
Musculoskeletal 0.066*** (0.003) 22.14 0.138*** (0.004) 45.95 
Infection 0.052*** (0.003) 16.95 0.133*** (0.004) 43.42 
Ear, nose, throat 0.012*** (0.002) 16.22 0.031*** (0.003) 43.25 
Circulatory 0.065*** (0.002) 13.09 0.167*** (0.004) 33.65 
Skin 0.013*** (0.002) 6.69 0.045*** (0.004) 22.69 
Eye 0.025*** (0.003) 4.63 0.045*** (0.004) 8.34 
Note: Sample size is 212,574. S.E. denotes robust standard errors. All logit regressions control for 
demographic, SES, lifestyle, family health history and QoL variables and year effects. The omitted 
group for SAH is excellent or very good.  Symbols *, **, and *** indicate significance at the 10%, 5%, 
and 1% level, respectively. a Mean refers to the mean of the dependent variable.  
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Table 8. Heterogeneity in average partial effects of SAH by gender and education 
  GP Specialist 
Other 
medical 
services Drugs Hospital 
A. Good SAH 
     Female 0.104*** 0.084*** 0.094*** 0.109*** 0.053*** 
 
(0.003) (0.004) (0.004) (0.003) (0.003) 
Male  0.081*** 0.088*** 0.084*** 0.097*** 0.052*** 
 
(0.004) (0.004) (0.004) (0.003) (0.004) 
No university degree 0.093*** 0.089*** 0.090*** 0.103*** 0.052*** 
 
(0.003) (0.003) (0.003) (0.003) (0.003) 
University degree 0.097*** 0.076*** 0.090*** 0.107*** 0.053*** 
 
(0.005) (0.005) (0.005) (0.004) (0.005) 
B. Fair/poor SAH 
     Female 0.211*** 0.202*** 0.207*** 0.236*** 0.139*** 
 
(0.005) (0.005) (0.005) (0.005) (0.005) 
Male  0.168*** 0.191*** 0.182*** 0.206*** 0.140*** 
 
(0.005) (0.005) (0.005) (0.005) (0.006) 
No university degree 0.193*** 0.200*** 0.193*** 0.222*** 0.141*** 
 
(0.005) (0.004) (0.004) (0.004) (0.005) 
University degree 0.192*** 0.188*** 0.206*** 0.231*** 0.134*** 
  (0.008) (0.008) (0.008) (0.007) (0.008) 
Pseudo R-squared 0.149 0.065 0.108 0.364 0.058 
Mean 0.453 0.487 0.478 0.406 0.256 
Notes: Sample size is 212,574. Robust standard errors are in parentheses. All logit regressions control 
for demographic, SES, lifestyle, family health history and QoL variables and year effects. The omitted 
group for SAH is excellent or very good. Symbols *, **, and *** indicate significance at the 10%, 5%, 
and 1% level, respectively. 
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Table 9. Comparison of predictive power of SAH and more objective health measures, pseudo 
R-squared statistics. 
 
 
Dependent Variable 
 
 
  Inclusion of health controls GP Specialist 
Other 
medical 
services Drugs Hospital  
1 Only non-health controls 0.140 0.057 0.099 0.349 0.054 
 Health variables added:       
2  SAH only 0.147 0.064 0.107 0.363 0.058 
3  Objective health (survey) only 0.161 0.080 0.124 0.390 0.068 
4  Objective health (admin) only 0.246 0.217 0.226 0.636 0.116 
5  SAH + Objective health (survey) 0.164 0.082 0.127 0.394 0.069 
6  SAH + Objective  health (admin) 0.246 0.218 0.227 0.636 0.117 
7 
 Objective health (survey) +      
     Objective health (admin) 0.249 0.220 0.229 0.637 0.118 
8 
 SAH + Objective health (survey) +  
     Objective health (admin) 0.249 0.220 0.230 0.637 0.119 
Notes: Sample size is 212,574. All logit regressions control for demographic, SES, lifestyle, family 
health history, QoL variables and year effects.  
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Figure 1. Heterogeneity in average partial effects of SAH by age. 
 
 
 
 
Notes: Sample size is 212,574. All logit regressions control for demographic, SES, lifestyle, family 
health history and QoL variables and year effects. The omitted group for SAH is excellent or very 
good.  
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